We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current DRUG market cap is 173.15M. The company's latest EPS is CAD -1.6515 and P/E is -23.52.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.23M | -2.24M | -1.45M | -814k | 228k |
Net Income | -1.46M | -1.53M | -1.68M | -574k | 230k |
Year End September 29 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -7.68M | -13.31M | -6.56M |
Net Income | -8.65M | -14.97M | -7.37M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |||
Total Assets | 8.46M | 6.88M | 6.89M | 6.53M | 6.28M |
Total Liabilities | 735k | 281k | 854k | 846k | 178k |
Total Equity | 7.73M | 6.6M | 6.03M | 5.69M | 6.1M |
Year End September 29 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 20.04M | 12.09M | 6.88M |
Total Liabilities | 639k | 1.54M | 281k |
Total Equity | 19.4M | 10.54M | 6.6M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |||
Operating | -5.83M | -7.03M | -822k | -1.63M | -1.39M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 2.21M | 2.19M | 878k | 856k | 834k |
Year End September 29 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |
Operating | -7.32M | -13.59M | -7.03M |
Investing | N/A | N/A | N/A |
Financing | 26.06M | 5.2M | 2.19M |
Market Cap | 173.15M |
Price to Earnings Ratio | -23.52 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 25.7 |
Price to Book Ratio | 26.28 |
Dividend Yield | - |
Shares Outstanding | 4.46M |
Average Volume (1 week) | 208.77k |
Average Volume (1 Month) | 214.66k |
52 Week Change | 2,593.75% |
52 Week High | 79.02 |
52 Week Low | 0.93 |
Spread (Intraday) | 10.79 (22.6%) |
Company Name | Bright Minds Biosciences Inc |
Address |
1500 - 1055 west georgia street vancouver, british columbia V6E 4N7 |
Website | https://www.brightmindsbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions